Sponsor Information 

Do not miss the opportunity to be part of the leading Meeting on Hypertension and Cardiovascular Protection, where the most influential players in cardiovascular disease field come together under one roof.

The sooner your organisation comes on board, the greater visibility you will gain from the ESH-ISH 2021 promotional campaign, and the larger your sponsorship level, the greater the additional benefits.

Explore the several Congress sponsorship opportunities and let the Organising team help you to put together a package that best fits your needs.
Our team will ensure that your investment leads to a successful Congress sponsorship experience.

Please contact us to receive the complete Sponsorship Opportunities for ESH-ISH 2021.


SPONSORSHIP & EXHIBITION MANAGEMENT

Any correspondence related to the exhibition should be addressed to:

 

AIM Italy srl
Via Flaminia, 1068 – 00189 Rome (Italy)
Ph. +39 06 330531

 

Exhibition Management: Monica Fusaro
E-mail: m.fusaro@aimgroup.eu


PHARMACEUTICAL COMPANIES & MEDICAL DEVICE INDUSTRY

For the promotion of their products, it is the sponsor’s responsibility to comply with:

  • PMCPA (Prescription Medicines Code of Practice Authority)
  • EFPIA code of practice (http://transparency.efpia.eu/the-efpia-code-2)*
  • EUCOMED code of practice (http://www.ethicalmedtech.eu/uploads/Modules/CodesDocs/afpm_en.pdf)


* Under the EFPIA code of practice, the sponsor is required to document and publicly disclose certain transfers
of value (as defined therein) made to healthcare professionals and healthcare organisations. The Organising Secretariat acknowledges and agrees that payments made by sponsor under this reservation form will be part of such disclosure.

 

ONLY FOR ITALIAN PHARMACEUTICAL COMPANIES

PROCEDURA IN ORDINE AI CONVEGNI, CONGRESSI E RIUNIONI DI CUI ALL’ART. 124 DEL D.LEG.IVO N. 219/06

Ogni impresa farmaceutica che produce e/o commercializza medicinali, organizza o contribuisce a realizzare, mediante finanziamenti o erogazione di altre utilità anche indiretti, un congresso, un convegno o una riunione su tematiche comunque attinenti all’impiego di medicinali dalla stessa impresa prodotti o commercializzati, deve trasmettere al competente ufficio dell’AIFA, almeno 60 giorni prima della data dell’inizio del congresso o incontro, richiesta di autorizzazione.

A tal proposito le Aziende dovranno far pervenire comunicazione scritta della propria partecipazione alla Segreteria Organizzativa AIM Italy (e-mail: m.fusaro@aimgroup.eu) entro e non oltre il 29 gennaio 2021.


L’agenzia incaricata per la pre-richiesta AIFA è AIM Education s.r.l. (e-mail: aifa@aimgroup.eu)

Si prega di notare che al suddetto servizio sarà applicato un fee.